The 21st Century Cures Act aims to support biomedical research. But along the way, it would exempt certain payments from drug companies to doctors. Critics say such changes are a mistake
The views, opinions and positions expressed by these authors and blogs are theirs and do not necessarily represent that of the Bioethics Research Library and Kennedy Institute of Ethics or Georgetown University.